Encompass Health Corporation $EHC Shares Bought by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC grew its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 35.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 128,451 shares of the company’s stock after purchasing an additional 33,872 shares during the period. Los Angeles Capital Management LLC’s holdings in Encompass Health were worth $15,004,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of EHC. WPG Advisers LLC grew its holdings in shares of Encompass Health by 73.3% in the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after acquiring an additional 137 shares during the period. Flagship Harbor Advisors LLC acquired a new stake in shares of Encompass Health in the 4th quarter worth approximately $37,000. Assetmark Inc. grew its holdings in shares of Encompass Health by 88.1% in the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after acquiring an additional 140 shares during the period. Caitong International Asset Management Co. Ltd grew its holdings in shares of Encompass Health by 36,200.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after acquiring an additional 362 shares during the period. Finally, Covestor Ltd grew its holdings in shares of Encompass Health by 24.4% in the 4th quarter. Covestor Ltd now owns 540 shares of the company’s stock worth $57,000 after acquiring an additional 106 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the sale, the executive vice president owned 24,755 shares in the company, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Barclays lowered their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. TD Cowen assumed coverage on Encompass Health in a report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price target on the stock. Finally, Leerink Partners set a $152.00 price target on Encompass Health in a report on Friday, May 22nd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average target price of $143.86.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $104.39 on Monday. The business’s fifty day moving average price is $103.79 and its two-hundred day moving average price is $104.96. The stock has a market cap of $10.36 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 2.27 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. The firm had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.Encompass Health’s quarterly revenue was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, analysts forecast that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health’s dividend payout ratio is 12.69%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.